A study examining the role of adriamycin in triple-negative breast cancer cells (TNBC) suggested that PMEPA1-positive cells had a higher phosphorylation profile of PI3K and AKT (22). This evidence concerns the gene PMEPA1 and triple-negative breast carcinoma.